Advancing the Science

Mayo Clinic Medical Science Blog

Aug 30, 2013 · Leave a Reply

Vedolizumab Effective for Treatment of Ulcerative Colitis & Crohn’s Disease – IBD in the News

By @

Sunanda Kane, M.D., a gastroenterologist at Mayo Clinic specializing in the care and evaluation of patients with IBD, discusses two studies recently published in “The New England Journal of Medicine” (ulcerative colitis study | Crohn's disease study) that found patients with ulcerative colitis or Crohn’s disease benefited from treatment with vedolizumab compared with placebo.

Dr. Kane also discusses how the mechanism of action for vedolizumab differs from other therapies currently used to treat IBD.

For more information on IBD, visit: mayoclinic.org/ibd

Please login or become a member to post a comment.

Contact Us · Privacy Policy